Adgero Biopharmaceuticals Holdings' Unattributed - II Round

Adgero Biopharmaceuticals Holdings raised a round of funding on April 19, 2016.

Adgero Biopharmaceuticals Holdings is a privately-held biopharmaceutical company focused on building a robust pipeline by advancing its proprietary late stage photodynamic therapy (PDT) product with b…

Articles about Adgero Biopharmaceuticals Holdings' Unattributed - II Round: